Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma
出版年份 2021 全文链接
标题
Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-09
DOI
10.1038/s41388-020-01590-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management
- (2020) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma
- (2019) Barbara Muz et al. HAEMATOLOGICA
- Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
- (2019) Harmen van Andel et al. LEUKEMIA
- Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma
- (2019) Ying Xie et al. ONCOGENE
- Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
- (2019) Juan-Jose Garcés et al. LEUKEMIA
- Pathogenesis of bone disease in multiple myeloma: from bench to bedside
- (2018) Evangelos Terpos et al. Blood Cancer Journal
- ARNT /HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
- (2018) Chuan Wu et al. Cancer Medicine
- Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma
- (2016) Huan Liu et al. Science Translational Medicine
- The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways
- (2016) Huili Zhu et al. Scientific Reports
- Dkk1 haploinsufficiency requires expression of Bmp2 for bone anabolic activity
- (2015) Giuseppe Intini et al. BONE
- Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
- (2015) Enrica Borsi et al. Translational Research
- The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas
- (2014) Ke-Tai Guo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Induction of Chemoresistance by All-Trans Retinoic Acid via a Noncanonical Signaling in Multiple Myeloma Cells
- (2014) Zhiqiang Liu et al. PLoS One
- Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention
- (2013) Fuling Zhou et al. BLOOD REVIEWS
- In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma
- (2013) Samantha Pozzi et al. BONE
- Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
- (2013) P Storti et al. LEUKEMIA
- p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction
- (2012) J. He et al. CANCER RESEARCH
- Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF- B Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop
- (2012) P. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- Genistein Affects Histone Modifications on Dickkopf-Related Protein 1 (DKK1) Gene in SW480 Human Colon Cancer Cell Line
- (2012) Huan Wang et al. PLoS One
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
- (2010) P. G. Richardson et al. BLOOD
- The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
- (2010) E. Martinez-Garcia et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
- (2008) Y.-W. Qiang et al. BLOOD
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started